IOIOF yields 3.58% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, IOIOF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IOIOF + PFE for your $10,000?
IOI Corporation Berhad, an investment holding company, engages in the plantation business in Malaysia, Europe, North America, Asia, and internationally. The company operates through two segments, Plantation and Resource-Based Manufacturing. It cultivates oil palm, softwood timber, and rubber; refines and processes crude palm and palm kernel oils; and manufactures specialty oils and fats. The company also manufactures and exports fatty acids, soap noodles, glycerine, fatty esters, and other related products. In addition, it is involved in the commercialization of clonal ramets and biotechnology related research and development activities; provision of management and marketing services; production and supply of palm-based renewable energy; and trading of palm oil commodities. Further, the company engages in the property development, maintenance, and investment activities; issuance of exchangeable bonds and guaranteed notes; storage tanks rental activities; manufacture, registration, trading, and distribution of oleochemical products; and provision of bulk cargo warehousing services, as well as treasury management services and management consulting services. It owns oil palm planted area of 176,980 hectares. The company was formerly known as Industrial Oxygen Incorporated Sdn Bhd and changed its name to IOI Corporation Berhad in March 1995. IOI Corporation Berhad was incorporated in 1969 and is based in Putrajaya, Malaysia.
Full IOIOF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.